Larimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference
Larimar Therapeutics, Inc. announced its participation in the Leerink Partners Global Biopharma Conference to present and engage in investor meetings. The company's management team will be present on March 13, 2024, at 10 AM ET. A webcast link is provided for those interested, and a replay will be accessible on Larimar's website for 30 days post-presentation.
03/06/2024 - 04:05 PM
BALA CYNWYD, Pa., March 06, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that members of the company’s management team will present and participate in 1x1 investor meetings at the Leerink Partners Global Biopharma Conference, taking place in Miami Beach, FL from March 11 – 13, 2024.
Details on the presentation can be found below.
Date: Wednesday, March 13, 2024https://wsw.com/webcast/leerink33/lrmr/2241008
Following the conclusion of the presentation, a replay will be available for 30 days on the “Events and Presentations ” page of Larimar’s website.
About Larimar Therapeutics https://larimartx.com .
Investor Contact: jallaire@lifesciadvisors.com
Company Contact: mcelano@larimartx.com
When is Larimar Therapeutics participating in the Leerink Partners Global Biopharma Conference?
Larimar Therapeutics is participating in the Leerink Partners Global Biopharma Conference from March 11 - 13, 2024.
What is the date and time of Larimar's presentation at the conference?
Larimar's presentation is scheduled for Wednesday, March 13, 2024, at 10 AM ET.
Where can interested individuals find the webcast link for Larimar's presentation?
The webcast link for Larimar's presentation can be accessed at https://wsw.com/webcast/leerink33/lrmr/2241008.
How long will the replay of Larimar's presentation be available?
The replay of Larimar's presentation will be available for 30 days on the 'Events and Presentations' page of Larimar's website.
LRMR Rankings
#3294 Ranked by Stock Gains
LRMR Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Pharmaceuticals: Major, Commercial Services, Miscellaneous Commercial Services, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
Bala Cynwyd
About LRMR
larimar therapeutics, inc. (nasdaq:lrmr), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. the company’s lead compound, cti-1601, is currently being evaluated in a phase 1 clinical program as a potential treatment for friedreich’s ataxia, a rare and progressive genetic disease. larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. for more information, please visit: https://larimartx.com.
